RxDoctor Payments Data

Andrea Lapp, NP

Nurse Practitioner · Billings, MTNPI 1942969431

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,699 of the $4,426 with a category attached, or 61.0%. 12 manufacturers reported payments, led by Edwards Lifesciences at 33.4% of the total. Among nurse practitioner clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,426in general payments, 2019–2025

Across 54 payments — averaging $81.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1K
  • Boston Scientific$1K
  • Abbott$406
  • Medtronic$337
  • Baxter Healthcare$180
  • Actelion Pharmaceuticals US, Inc.$150
  • plus $421 from 6 others

What the payments were for

  • Travel & lodging$1,65937%
  • Food & beverage$2,69961%
  • Education$682%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,426 in reported general payments places this provider in the 95th percentile of 357 nurse practitioner providers in Montana.

See all nurse practitioner providers in Montana

Medicare billing

Part B allowed, 2024
$47,718
Medicare patients
399
Services billed
574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban137$127,022
EntrestoSacubitril/Valsartan33$33,887
XareltoRivaroxaban16$19,606
FarxigaDapagliflozin Propanediol17$15,939
JardianceEmpagliflozin20$11,747
Metoprolol Succinate253$2,971
Flecainide Acetate20$1,418
Atorvastatin Calcium150$1,386
ClopidogrelClopidogrel Bisulfate159$1,362
Amiodarone Hcl18$1,351
Losartan Potassium129$1,161
Potassium Chloride56$1,067
Carvedilol111$718
Spironolactone145$650
Isosorbide Mononitrate ErIsosorbide Mononitrate53$378

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$29$33,88733 claims
AstraZenecaFarxiga$57$15,93917 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 357 nurse practitioner providers in Montana.

Other nurse practitioner in Billings

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →